Acurx Pharmaceuticals, Inc. (ACXP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.73M |
| Enterprise Value | -3.82M |
| P/E Ratio | -0.29 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.54 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.65 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.68 |
| Return On Equity | -1.25 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -7.97M |
| Net Income | -7.97M |
| Diluted EPS | -5.32 |
Balance Sheet
| Total Cash | 10.66M |
| Total Cash/Share | 2.5 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.88 |
| Book Value Per Share | 1.91 |
Price History
| 52-Week Change | -81.43 |
| 52-Week High | 7.54 |
| 52-Week Low | 0.95 |
| Moving Average 50 Days | 1.24 |
| Moving Average 200 Days | 1.92 |
Statistics
| Average Volume | 124,314 |
| Shares Outstanding | 5.56M |
| % Held by Institutions | 2.92 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | August 05, 2025 |
AD
